Karin is currently our Vice President of Toxicology, who previously served as the Senior Director of Pharmacology. Prior to joining Contineum Therapeutics, she was Associate Director of Biology at Inception Sciences where she led the in vivo pharmacology group to drive preclinical pharmacology and toxicology efforts in support of multiple research programs including the Inception 5 remyelination company which was acquired by Roche. Karin’s professional experience encompasses a diverse range of therapeutic areas including multiple sclerosis, hearing, ophthalmology, oncology, fibrosis, allergic asthma, COPD, and osteoporosis. Prior to joining Inception Sciences, Karin held Senior Scientist positions at Amira Pharmaceuticals, Organon Research Center USA, and UCB Research, and was initiated into drug discovery at Ariad Pharmaceuticals. Karin received a B.Sc. in Physiology from McGill University.
« Go Back
